BiTEs: bispecific antibody constructs with unique anti-tumor activityWOLF, Evelyn; HOFMEISTER, Robert; KUFER, Peter et al.Drug discovery today. 2005, Vol 10, Num 18, pp 1237-1244, issn 1359-6446, 8 p.Article

A revival of bispecific antibodiesKUFER, Peter; LUTTERBÜSE, Ralf; BAEUERLE, Patrick A et al.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 5, pp 238-244, issn 0167-7799, 7 p.Article

A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applicationsBYRNE, Hannah; CONROY, Paul J; WHISSTOCK, James C et al.Trends in biotechnology (Regular ed.). 2013, Vol 31, Num 11, pp 621-632, issn 0167-7799, 12 p.Article

Construction of Optimized Bispecific Antibodies for Selective Activation of the Death Receptor CD95HERRMANN, Tanja; GROSSE-HOVEST, Ludger; OTZ, Tina et al.Cancer research (Baltimore). 2008, Vol 68, Num 4, pp 1221-1227, issn 0008-5472, 7 p.Article

Antitumor Immunity: Easy as 1, 2, 3 with Monoclonal Bispecific Trifunctional Antibodies?MAHER, John; ADAMI, Antonella A.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 18, pp 5613-5617, issn 0008-5472, 5 p.Article

Antitumour effects of a bispecific trivalent antibody in multicellular tumour spheroidsWALZ, Annette; MACK, Brigitte; SCHMITT, Bärbel et al.Anticancer research. 2004, Vol 24, Num 2B, pp 887-893, issn 0250-7005, 7 p.Article

Potent Immunomodulatory Effects of the Trifunctional Antibody CatumaxomabGOERE, Diane; FLAMENT, Caroline; ZITVOGEL, Laurence et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 15, pp 4663-4673, issn 0008-5472, 11 p.Article

Les anticorps thérapeutiques bispécifiques: deux fois plus puissants ?DUMONTET, Charles.Bulletin du cancer. 2011, Vol 98, Num 12, pp 1381-1382, issn 0007-4551, 2 p.Article

The assembly of single domain antibodies into bispecific decavalent moleculesSTONE, Emily; HIRAMA, Tomoko; TANHA, Jamshid et al.Journal of immunological methods. 2007, Vol 318, Num 1-2, pp 88-94, issn 0022-1759, 7 p.Article

Anticorps recombinants : vers une nouvelle génération d'antivenins ? = Recombinant antibodies: towards a new generation of antivenoms?AUBREY, Nicolas; MUZARD, Julien; JUSTE, Matthieu et al.Journal de la Société de biologie. 2006, Vol 200, Num 4, pp 345-354, issn 1295-0661, 10 p.Conference Paper

Efficient bispecific monoclonal antibody purification using gradient thiophilic affinity chromatographyKREUTZ, F. T; WISHART, D. S; SURESH, M. R et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 714, Num 2, pp 161-170, issn 1387-2273Article

Two examples of an inseparable antibody that reacts equally well with D^W+ and RH32+ red blood cellsREID, M. E; SAUSAIS, L; ZAROULIS, C. G et al.Vox sanguinis (Basel. 1956). 1998, Vol 75, Num 3, pp 230-233, issn 0042-9007Article

Clinical perspectives of bispecific antibodies in cancerDE GAST, G. C; VAN DE WINKEL, J. G. J; BAST, B. E. J. E. G et al.Cancer immunology and immunotherapy. 1997, Vol 45, Num 3-4, pp 121-123, issn 0340-7004Conference Paper

Idiotypic study of a bispecific thyroglobulin and thyroperoxidase monoclonal antibodyVILLA, M; DURAND-GORDE, J.-M; CARAYON, P et al.Journal of autoimmunity (Print). 1996, Vol 9, Num 5, pp 653-660, issn 0896-8411Article

Controlling orientation of functional proteinsKOYAMA, K.Yukagaku. 1996, Vol 45, Num 8, pp 715-722, issn 0513-398XArticle

Development of a bispecific monoclonal antibody as a universal immunoprobe for detecting biotinylated macromoleculesCAO, Y; CHRISTIAN, S; SURESH, M. R et al.Journal of immunological methods. 1998, Vol 220, Num 1-2, pp 85-91, issn 0022-1759Article

L'envol des anticorps bispécifiques : IMMUNO-ONCOLOGIE: Le combat biotech contre le cancerFISCHER, Nicolas.Biofutur (Puteaux). 2014, Vol 352, pp 30-33, issn 0294-3506, 4 p.Article

Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumorsMOOSMAYER, Dieter; BERNDORFF, Dietmar; DINKELBORG, Ludger M et al.Clinical cancer research. 2006, Vol 12, Num 18, pp 5587-5595, issn 1078-0432, 9 p.Article

Targeting of Porphyromonas gingivalis with a bispecific antibody directed to FcαRI (CD89) improves in vitro clearance by gingival crevicular neutrophilsKOBAYASHI, Tetsuo; TAKAUCHI, Ayano; VAN SPRIEL, Annemiek B et al.Vaccine. 2004, Vol 23, Num 5, pp 585-594, issn 0264-410X, 10 p.Article

Evaluation of antigen-specific responses using in vitro enriched T cellsJONES, N; AGRAWAL, D; ELREFAEI, M et al.Journal of immunological methods. 2003, Vol 274, Num 1-2, pp 139-147, issn 0022-1759, 9 p.Article

Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2DAN LU; KOTANIDES, H; JIMENEZ, X et al.Journal of immunological methods. 1999, Vol 230, Num 1-2, pp 159-171, issn 0022-1759Article

Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300aBACHELET, Ido; MUNITZ, Ariel; LEVI-SCHAFFER, Francesca et al.Journal of allergy and clinical immunology. 2006, Vol 117, Num 6, pp 1314-1320, issn 0091-6749, 7 p.Article

Trifunctional Bispecific Antibodies Induce Tumor-Specific T Cells and Elicit a Vaccination EffectEISSLER, Nina; RUF, Peter; MYSLIWIETZ, Josef et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 16, pp 3958-3966, issn 0008-5472, 9 p.Article

A Bispecific Antibody Composed of a Nonneutralizing Antibody to the gp41 Immunodominant Region and an Anti-CD89 Antibody Directs Broad Human Immunodeficiency Virus Destruction by NeutrophilsDUVAL, Mark; POSNER, Marshall R; CAVACINI, Lisa A et al.Journal of virology. 2008, Vol 82, Num 9, pp 4671-4674, issn 0022-538X, 4 p.Article

Characterisation of the new EpCAM-specific antibody HO-3 : implications for trifunctional antibody immunotherapy of cancerRUF, P; GIRES, O; JAGER, M et al.British journal of cancer. 2007, Vol 97, Num 3, pp 315-321, issn 0007-0920, 7 p.Article